Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Catheter Precision (VTAK) Shares Outstanding (Weighted Average) (2017 - 2025)

Historic Shares Outstanding (Weighted Average) for Catheter Precision (VTAK) over the last 9 years, with Q3 2025 value amounting to $1.3 million.

  • Catheter Precision's Shares Outstanding (Weighted Average) rose 112327.89% to $1.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 million, marking a year-over-year increase of 112327.89%. This contributed to the annual value of $3.3 million for FY2024, which is 49391.16% up from last year.
  • Latest data reveals that Catheter Precision reported Shares Outstanding (Weighted Average) of $1.3 million as of Q3 2025, which was up 112327.89% from $13.3 million recorded in Q2 2025.
  • Catheter Precision's Shares Outstanding (Weighted Average)'s 5-year high stood at $1.1 billion during Q3 2022, with a 5-year trough of $128.0 in Q3 2021.
  • Moreover, its 5-year median value for Shares Outstanding (Weighted Average) was $757340.0 (2024), whereas its average is $114.5 million.
  • As far as peak fluctuations go, Catheter Precision's Shares Outstanding (Weighted Average) plummeted by 9999.46% in 2021, and later soared by 85331161875.0% in 2022.
  • Over the past 5 years, Catheter Precision's Shares Outstanding (Weighted Average) (Quarter) stood at $101000.0 in 2021, then soared by 923.59% to $1.0 million in 2022, then crashed by 46.85% to $549507.0 in 2023, then surged by 493.91% to $3.3 million in 2024, then plummeted by 59.54% to $1.3 million in 2025.
  • Its Shares Outstanding (Weighted Average) stands at $1.3 million for Q3 2025, versus $13.3 million for Q2 2025 and $11.3 million for Q1 2025.